Cell Receptor Inc. has IP for remarkably improving treatment results in oncology by targeting critical upstream steps of growth signaling, not noticed in oncology yet. A well-tolerated affordable treatment of low toxicity! It will prevent metastasis in most cancers.

Location
Additional address info
  • c/o L&S Trust Services SA
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in